Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: WHR stock price vs HCA: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at HCA's multiple
Needs HCA P/E.
Implied fair value · at WHR's multiple
Needs WHR P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
WHIRLPOOL CORP /DE/ · implied price per share
Bear
-$46.25
Base
-$39.05
Bull
-$26.28
HCA Healthcare, Inc. · implied price per share
Bear
$130.81
Base
$187.37
Bull
$261.03
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
BEST BUY CO INC
WHR vs BBY
HOME DEPOT, INC.
WHR vs HD
GENERAL ELECTRIC CO
WHR vs GE
HELEN OF TROY LTD
WHR vs HELE
NEWELL BRANDS INC.
WHR vs NWL
Spectrum Brands Holdings, Inc.
WHR vs SPB
LABCORP HOLDINGS INC.
WHR vs LH
WEST PHARMACEUTICAL SERVICES INC
WHR vs WST
BAXTER INTERNATIONAL INC
WHR vs BAX
MCKESSON CORP
WHR vs MCK
Cigna Group
WHR vs CI
UNITEDHEALTH GROUP INC
WHR vs UNH
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe WHR can stabilize revenue, sustain margins near current levels, and de-lever over time, then the stock looks attractive on a rerating basis because it trades far below the P/E-implied and DCF valuation ranges; otherwise, the current discount looks justified by weaker growth, lower profitability, and higher leverage versus HCA.
WHR trades at 6.7x P/E versus HCA at 14.5x and 0.2x P/S versus HCA at 1.2x, indicating a substantial valuation gap on earnings and sales multiples. However, EV/EBITDA is similar at 5.7x for WHR and 5.4x for HCA, suggesting the apparent cheapness is less pronounced on an operating cash-flow basis.
Supporting Metrics
